Finnegan Kelsey, Smalley Julia, Gallagher Barbara, Salt Michael, Whalen Kimberly, Flaherty Michael R
Division of Pediatric Critical Care Medicine, MassGeneral Brigham for Children, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.
Pediatr Res. 2025 Mar 27. doi: 10.1038/s41390-025-04022-z.
The benefits of enteral feeding in critically ill children have been well described, but the use of non-invasive respiratory support has been shown to delay initiation of feeds, in part due to safety concerns. We aimed to examine the association of enteral feeding by mouth and orogastric tube on clinically significant adverse events in children with bronchiolitis being treated with non-invasive respiratory support via nasal interfaces.
A retrospective cohort study of patients 0-24 months of age between 2016 and 2022 in a quaternary care hospital pediatric intensive care unit with a diagnosis of bronchiolitis and treatment with non-invasive respiratory support via nasal interface. Standard comparative statistics and multivariable regression were used to determine the association between oral and nasogastric feeding and clinically significant outcomes such as new diagnosis of pneumonia and escalation in respiratory support, as well lengths of stay.
There were 407 patients 24 months or younger who were admitted with bronchiolitis and treated with non-invasive respiratory support. There was a 4.65 increased odds of developing a new pneumonia for patients who were fed nasogastrically versus orally. There were no differences in the development of pneumonia based on type of respiratory support, whether an escalation in respiratory support was needed, or based on the highest level of support received. Both pediatric intensive care unit and overall hospital lengths of stay were decreased in those who were orally fed.
Enteral feeding in children with bronchiolitis receiving non-invasive respiratory support appears to be safe and not associated with escalation in support or new diagnoses of pneumonia. Oral feeds were associated with decreased lengths of stay. Further work is needed to assess long term safety and ability to achieve adequate nutritional requirements.
Enteral feeding of children with bronchiolitis requiring non-invasive respiratory support via nasal interfaces did not have an effect on clinically significant adverse events Feeding by mouth led to decreased risk of pneumonia and shorter inpatient length of stay Future work is needed to study the ability to achieve nutrition goals when feeding by mouth on non-invasive support.
肠内喂养对危重症儿童的益处已得到充分描述,但无创呼吸支持的使用已被证明会延迟喂养的开始,部分原因是出于安全考虑。我们旨在研究经口和经鼻胃管进行肠内喂养与通过鼻接口接受无创呼吸支持治疗的毛细支气管炎患儿临床上显著不良事件之间的关联。
对2016年至2022年期间在一家四级医疗医院儿科重症监护病房诊断为毛细支气管炎并通过鼻接口接受无创呼吸支持治疗的0至24个月大的患者进行回顾性队列研究。使用标准比较统计和多变量回归来确定口服和鼻胃管喂养与临床上显著结局之间的关联,如肺炎的新诊断和呼吸支持的升级,以及住院时间。
有407名24个月及以下的患者因毛细支气管炎入院并接受无创呼吸支持治疗。与经口喂养的患者相比,经鼻胃管喂养的患者发生新肺炎的几率增加了4.65倍。基于呼吸支持类型、是否需要呼吸支持升级或基于所接受的最高支持水平,肺炎的发生没有差异。口服喂养的患者在儿科重症监护病房和总体住院时间均缩短。
接受无创呼吸支持的毛细支气管炎患儿进行肠内喂养似乎是安全的,且与支持升级或肺炎新诊断无关。口服喂养与住院时间缩短有关。需要进一步开展工作来评估长期安全性以及满足充足营养需求的能力。
对需要通过鼻接口进行无创呼吸支持的毛细支气管炎患儿进行肠内喂养对临床上显著的不良事件没有影响。经口喂养可降低肺炎风险并缩短住院时间。未来需要开展工作来研究在无创支持下经口喂养时实现营养目标的能力。